{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T20:38:44Z","timestamp":1792701524546,"version":"4.5.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2006,5,2]],"date-time":"2006-05-02T00:00:00Z","timestamp":1146528000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2006,7]]},"DOI":"10.1007\/s10875-006-9022-6","type":"journal-article","created":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T18:37:49Z","timestamp":1146508669000},"page":"299-307","source":"Crossref","is-referenced-by-count":241,"title":["Matrix Metalloproteinase-9 and Autoimmune Diseases"],"prefix":"10.1007","volume":"26","author":[{"given":"Maya","family":"Ram","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaniv","family":"Sherer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yehuda","family":"Shoenfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2006,5,2]]},"reference":[{"key":"9022_CR1","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1023\/A:1026028303196","volume":"253","author":"S Chakraborti","year":"2003","unstructured":"Chakraborti S, Mandal M, Das S, Mandal A, Chakraborti T: Regulation of matrix metalloproteinases: An overview. Mol Cell Biochem 253:269\u2013285, 2003.","journal-title":"Mol Cell Biochem"},{"key":"9022_CR2","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.ceb.2004.07.010","volume":"16","author":"JD Mott","year":"2004","unstructured":"Mott JD, Werb Z: Regulation of matrix biology by matrix metalloproteinases. Curr Opin Cell Biol 16:558\u2013564, 2004.","journal-title":"Curr Opin Cell Biol"},{"key":"9022_CR3","doi-asserted-by":"crossref","first-page":"21491","DOI":"10.1074\/jbc.274.31.21491","volume":"274","author":"H Nagase","year":"1999","unstructured":"Nagase H, Woessner JF, Jr: Matrix metalloproteinases. J Biol Chem 274:21491\u201321494, 1999.","journal-title":"J Biol Chem"},{"key":"9022_CR4","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1023\/A:1025526424637","volume":"252","author":"M Mandal","year":"2003","unstructured":"Mandal M, Mandal A, Das S, Chakraborti T, Sajal C: Clinical implications of matrix metalloproteinases. Mol Cell Biochem 252:305\u2013329, 2003.","journal-title":"Mol Cell Biochem"},{"key":"9022_CR5","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1080\/10409230290771546","volume":"37","author":"PE Van den Steen","year":"2002","unstructured":"Van den Steen PE, Dubois B, Nelissen I, Rudd PM, Dwek RA, Opdenakker G: Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9). Crit Rev Biochem Mol Biol 37:375\u2013536, 2002.","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"9022_CR6","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S1471-4906(01)02023-3","volume":"22","author":"G Opdenakker","year":"2001","unstructured":"Opdenakker G, Van den Steen PE, Van Damme J: Gelatinase B: A tuner and amplifier of immune functions. Trends Immunol 22:571\u2013579, 2001.","journal-title":"Trends Immunol"},{"key":"9022_CR7","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1189\/jlb.69.6.851","volume":"69","author":"G Opdenakker","year":"2001","unstructured":"Opdenakker G, Van den Steen PE, Dubois B, Nelissen I, Van Coillie E, Masure S, Proost P, Van Damme J: Gelatinase B functions as regulator and effector in leukocyte biology. J Leukoc Biol 69:851\u2013859, 2001.","journal-title":"J Leukoc Biol"},{"key":"9022_CR8","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/S1357-2725(01)00007-3","volume":"33","author":"M Nguyen","year":"2001","unstructured":"Nguyen M, Arkell J, Jackson CJ: Human endothelial gelatinases and angiogenesis. Int J Biochem Cell Biol 33:960\u2013970, 2001.","journal-title":"Int J Biochem Cell Biol"},{"key":"9022_CR9","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0896-8411(03)00037-4","volume":"20","author":"C Matache","year":"2003","unstructured":"Matache C, Stefanescu M, Dragomir C, Tanaseanu S, Onu A, Ofiteru A, Szegli G: Matrix metalloproteinase-9 and its natural inhibitor TIMP-1 expressed or secreted by peripheral blood mononuclear cells from patients with systemic lupus erythematosus. J Autoimmun 20:323\u2013331, 2003.","journal-title":"J Autoimmun"},{"key":"9022_CR10","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1046\/j.1365-2249.2002.01758.x","volume":"127","author":"A Faber-Elmann","year":"2002","unstructured":"Faber-Elmann A, Sthoeger Z, Tcherniack A, Dayan M, Mozes E: Activity of matrix metalloproteinase-9 is elevated in sera of patients with systemic lupus erythematosus. Clin Exp Immunol 127:393\u2013398, 2002.","journal-title":"Clin Exp Immunol"},{"key":"9022_CR11","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1136\/mp.56.4.244","volume":"56","author":"GS Makowski","year":"2003","unstructured":"Makowski GS, Ramsby ML: Concentrations of circulating matrix metalloproteinase 9 inversely correlate with autoimmune antibodies to double stranded DNA: Implications for monitoring disease activity in systemic lupus erythematosus. Mol Pathol 56:244\u2013247, 2003.","journal-title":"Mol Pathol"},{"key":"9022_CR12","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0945-053X(98)90086-5","volume":"17","author":"YT Konttinen","year":"1998","unstructured":"Konttinen YT, Halinen S, Hanemaaijer R, Sorsa T, Hietanen J, Ceponis A, Xu JW, Manthorpe R, Whittington J, Larsson A, Salo T, Kjeldsen L, Stenman UH, Eisen AZ: Matrix metalloproteinase (MMP)-9 type IV collagenase\/gelatinase implicated in the pathogenesis of Sjogren's syndrome. Matrix Biol 17:335\u2013347, 1998.","journal-title":"Matrix Biol"},{"key":"9022_CR13","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1002\/1529-0131(200012)43:12<2807::AID-ANR22>3.0.CO;2-M","volume":"43","author":"P Perez","year":"2000","unstructured":"Perez P, Goicovich E, Alliende C, Aguilera S, Leyton C, Molina C, Pinto R, Romo R, Martinez B, Gonzalez MJ: Differential expression of matrix metalloproteinases in labial salivary glands of patients with primary Sjogren's syndrome. Arthritis Rheum 43:2807\u20132817, 2000.","journal-title":"Arthritis Rheum"},{"key":"9022_CR14","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0945-053X(98)90116-0","volume":"17","author":"R Hanemaaijer","year":"1998","unstructured":"Hanemaaijer R, Visser H, Konttinen YT, Koolwijk P, Verheijen JH: A novel and simple immunocapture assay for determination of gelatinase-B (MMP-9) activities in biological fluids: Saliva from patients with Sjogren's syndrome contain increased latent and active gelatinase-B levels. Matrix Biol 17:657\u2013665, 1998.","journal-title":"Matrix Biol"},{"key":"9022_CR15","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1046\/j.1365-2230.2002.01011.x","volume":"27","author":"K Kikuchi","year":"2002","unstructured":"Kikuchi K, Kubo M, Hoashi T, Tamaki K: Decreased MMP-9 activity in the serum of patients with diffuse cutaneous systemic sclerosis. Clin Exp Dermatol 27:301\u2013305, 2002.","journal-title":"Clin Exp Dermatol"},{"key":"9022_CR16","doi-asserted-by":"crossref","first-page":"R71","DOI":"10.1186\/ar1454","volume":"7","author":"WU Kim","year":"2005","unstructured":"Kim WU, Min SY, Cho ML, Hong KH, Shin YJ, Park SH, Cho CS: Elevated matrix metalloproteinase-9 in patients with systemic sclerosis. Arthritis Res Ther 7:R71\u2013R79, 2005. Epub 2004 Nov 10.","journal-title":"Arthritis Res Ther"},{"key":"9022_CR17","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/brain\/124.2.341","volume":"124","author":"BC Kieseier","year":"2001","unstructured":"Kieseier BC, Schneider C, Clements JM, Gearing AJ, Gold R, Toyka KV, Hartung HP: Expression of specific matrix metalloproteinases in inflammatory myopathies. Brain 124:341\u2013351, 2001.","journal-title":"Brain"},{"key":"9022_CR18","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1212\/WNL.54.1.65","volume":"54","author":"YC Choi","year":"2000","unstructured":"Choi YC, Dalakas MC: Expression of matrix metalloproteinases in the muscle of patients with inflammatory myopathies. Neurology 54:65\u201371, 2000.","journal-title":"Neurology"},{"key":"9022_CR19","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1136\/ard.62.11.1094","volume":"62","author":"I Tchetverikov","year":"2003","unstructured":"Tchetverikov I, Lard LR, DeGroot J, Verzijl N, TeKoppele JM, Breedveld FC, Huizinga TW, Hanemaaijer R: Matrix metalloproteinases-3, -8, -9 as markers of disease activity and joint damage progression in early rheumatoid arthritis. Ann Rheum Dis 62:1094\u20131099, 2003.","journal-title":"Ann Rheum Dis"},{"key":"9022_CR20","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1006\/clin.1996.0025","volume":"78","author":"BL Gruber","year":"1996","unstructured":"Gruber BL, Sorbi D, French DL, Marchese MJ, Nuovo GJ, Kew RR, Arbeit LA: Markedly elevated serum MMP-9 (gelatinase B) levels in rheumatoid arthritis: A potentially useful laboratory marker. Clin Immunol Immunopathol 78:161\u2013171, 1996.","journal-title":"Clin Immunol Immunopathol"},{"issue":"Pt 12","key":"9022_CR21","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1093\/brain\/121.12.2327","volume":"121","author":"D Leppert","year":"1998","unstructured":"Leppert D, Ford J, Stabler G, Grygar C, Lienert C, Huber S, Miller KM, Hauser SL, Kappos L: Matrix metalloproteinase-9 (gelatinase B) is selectively elevated in CSF during relapses and stable phases of multiple sclerosis. Brain 121(Pt 12):2327\u20132334, 1998.","journal-title":"Brain"},{"key":"9022_CR22","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1191\/1352458504ms1058oa","volume":"10","author":"J Sastre-Garriga","year":"2004","unstructured":"Sastre-Garriga J, Comabella M, Brieva L, Rovira A, Tintore M, Montalban X: Decreased MMP-9 production in primary progressive multiple sclerosis patients. Mult Scler 10:376\u2013380, 2004.","journal-title":"Mult Scler"},{"key":"9022_CR23","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1191\/1352458502ms800oa","volume":"8","author":"GM Liuzzi","year":"2002","unstructured":"Liuzzi GM, Trojano M, Fanelli M, Avolio C, Fasano A, Livrea P, Riccio P: Intrathecal synthesis of matrix metalloproteinase-9 in patients with multiple sclerosis: Implication for pathogenesis. Mult Scler 8:222\u2013228, 2002.","journal-title":"Mult Scler"},{"issue":"Pt 1","key":"9022_CR24","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/brain\/121.1.159","volume":"121","author":"BC Kieseier","year":"1998","unstructured":"Kieseier BC, Kiefer R, Clements JM, Miller K, Wells GM, Schweitzer T, Gearing AJ, Hartung HP: Matrix metalloproteinase-9 and -7 are regulated in experimental autoimmune encephalomyelitis. Brain 121(Pt 1):159\u2013166, 1998.","journal-title":"Brain"},{"key":"9022_CR25","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1568-9972(01)00003-9","volume":"1","author":"Y Sherer","year":"2002","unstructured":"Sherer Y, Shoenfeld Y: Immunomodulation for treatment and prevention of atherosclerosis. Autoimmun Rev 1:21\u201327, 2002.","journal-title":"Autoimmun Rev"},{"key":"9022_CR26","first-page":"1825","volume":"117","author":"X Jiang","year":"2004","unstructured":"Jiang X, Zeng HS, Guo Y, Zhou ZB, Tang BS, Li FK: The expression of matrix metalloproteinases-9, transforming growth factor-beta1 and transforming growth factor-beta receptor I in human atherosclerotic plaque and their relationship with plaque stability. Chin Med J (Engl) 117:1825\u20131829, 2004.","journal-title":"Chin Med J (Engl)"},{"key":"9022_CR27","first-page":"57","volume":"15","author":"F Chen","year":"2005","unstructured":"Chen F, Eriksson P, Hansson GK, Herzfeld I, Klein M, Hansson LO, Valen G: Expression of matrix metalloproteinase 9 and its regulators in the unstable coronary atherosclerotic plaque. Int J Mol Med 15:57\u201365, 2005.","journal-title":"Int J Mol Med"},{"key":"9022_CR28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10016-004-0131-5","volume":"19","author":"Sebastian Stintzing, MD, peter Heuschmann, MD, Letterio Barbera, MD, Matthias Ocker, MD Andreas Jung, PhD, Thomas Kirchner, MD, and Daniel Neureiter, MD, Erlangen, Muenster, and Bochum, Germany","year":"2005","unstructured":"Sebastian Stintzing, MD, peter Heuschmann, MD, Letterio Barbera, MD, Matthias Ocker, MD Andreas Jung, PhD, Thomas Kirchner, MD, and Daniel Neureiter, MD, Erlangen, Muenster, and Bochum, Germany: Overexpression of MMP9 and Tissue Factor in unstable carotid plaques associated with Chlamydia pneumoniae, inflammation, and apoptosis. Ann Vasc Surg 19:1\u201310, 2005.","journal-title":"Ann Vasc Surg"},{"key":"9022_CR29","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1002\/cncr.10905","volume":"95","author":"S Shapiro","year":"2002","unstructured":"Shapiro S, Shoenfeld Y, Gilburd B, Sobel E, Lahat N: Intravenous gamma globulin inhibits the production of matrix metalloproteinase-9 in macrophages. Cancer 95:2032\u20132037, 2002.","journal-title":"Cancer"},{"key":"9022_CR30","doi-asserted-by":"crossref","first-page":"5988","DOI":"10.1210\/jcem.86.12.8212","volume":"86","author":"A Aljada","year":"2001","unstructured":"Aljada A, Ghanim H, Mohanty P, Hofmeyer D, Tripathy D, Dandona P: Hydrocortisone suppresses intranuclear activator-protein-1 (AP-1) binding activity in mononuclear cells and plasma matrix metalloproteinase 2 and 9 (MMP-2 and MMP-9). J Clin Endocrinol Metab 86:5988\u20135991, 2001.","journal-title":"J Clin Endocrinol Metab"},{"key":"9022_CR31","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1111\/j.1398-9995.2004.00516.x","volume":"59","author":"M Profita","year":"2004","unstructured":"Profita M, Gagliardo R, Di Giorgi R, Bruno A, Riccobono L, Bonanno A, Bousquet J, Vignola AM: In vitro effects of flunisolide on MMP-9, TIMP-1, fibronectin, TGF-beta1 release and apoptosis in sputum cells freshly isolated from mild to moderate asthmatics. Allergy 59:927\u2013932, 2004.","journal-title":"Allergy"},{"key":"9022_CR32","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1212\/WNL.46.6.1626","volume":"46","author":"GA Rosenberg","year":"1996","unstructured":"Rosenberg GA, Dencoff JE, Correa N, Reiners M, Ford CC: Effect of steroid on CNS matrix metalloproteinases in multiple sclerosis: Relation to blood-brain barrier injury. Neurology 46:1626\u20131632, 1996.","journal-title":"Neurology"},{"key":"9022_CR33","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1001\/archneur.61.6.929","volume":"61","author":"BC Kieseier","year":"2004","unstructured":"Kieseier BC, Archelos JJ, Hartung HP: Different effects of simvastatin and interferon beta on the proteolytic activity of matrix metalloproteinases. Arch Neurol 61:929\u2013932, 2004.","journal-title":"Arch Neurol"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-006-9022-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10875-006-9022-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-006-9022-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,7]],"date-time":"2023-05-07T08:37:21Z","timestamp":1683448641000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10875-006-9022-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5,2]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,7]]}},"alternative-id":["9022"],"URL":"https:\/\/doi.org\/10.1007\/s10875-006-9022-6","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,5,2]]}}}